Medical start-up RxFunction Inc raises $7.5 million in Series A
Medical start-up RxFunction, Inc., a wearable technology company that created walkasins® - the first Wearable Sensory Prosthesis - has completed its Series A funding round, raising $7.5 million and surpassing the initial funding goal of $5 million.
Get immediate results with new blood test technology
Researchers have created a mobile version of the "Enzyme Linked Immunosorbent Assay" (ELISA), the gold standard technique used to detect the presence of an antibody or antigen. Instead of sending patients to a laboratory, new cell phone-based technology allows for the very same test to be conducted in the doctor's office, clinic or even in a remote area.
IDTechEx interviewed Aleksandr Shtukater, founder of Raayonnova, about their progress developing smart contact lenses integrating displays.
Trial of first bioelectronic device to treat rheumatoid arthritis
A pilot trial for patients with drug refractory rheumatoid arthritis in the U.S. The multi-center study, "A Randomized Controlled Study of the Safety and Efficacy of Neurostimula- tion Using a Vagus Nerve Stimulation Device in Patients with Rheumatoid Arthritis," assesses the safety and efficacy of a proprietary bioelectronic device in adult patients with RA who are not adequately responsive to multiple biologic agents.
Tissue Engineering and Regenerative Medicine
The aim of tissue engineering and regenerative medicine is to create living biological tissue that can repair and replace damaged tissues in the body, something that cannot be achieved by medicine and medical procedures.
Neuromodulation for migrane relief
electroCore, LLC has received clearance from the U.S. Food and Drug Administration for an expanded label for gammaCore as an acute treatment of pain associated with migraine in adult patients. gammaCore therapy is a proprietary, non-invasive neuromodulation treatment delivered by a hand-held unit that stimulates the vagus nerve through the skin.
CRISPR enhances cancer immunotherapy
Last year, the Food and Drug Administration approved the first cellular immunotherapies to treat cancer. These therapies involve collecting a patient's own immune cells -- called T cells -- and supercharging them to home in on and attack specific blood cancers, such as hard-to-treat acute lymphoblastic leukemia and non-Hodgkin lymphoma.
AI to help stroke victims
The U.S. Food and Drug Administration has granted a De Novo request for the first-ever Computer-Aided Triage and Notification Platform to identify Large Vessel Occlusion strokes in CTA imaging.
Human-on-a-Chip: using tissue engineering to replicate the human body
An application of tissue engineering that is rapidly growing is the building of organ-on-a-chip devices.
Implanted continuous glucose sensor proven safe
Results of the PRECISE II study showed the implanted continuous glucose monitoring (CGM) system from Eversense to be safe and highly accurate over the 90-day sensor life in patients with type 1 or type 2 diabetes.
IDTechEx analyst Nadia Tsao interviewed Histogenics CTO Stephen Kennedy on August 17, 2017. Histogenics is a regenerative medicine company focused on developing solutions for the musculoskeletal system.
IDTechEx analyst Nadia Tsao interviewed BellaSeno co-founder and CTO Dr Mohit Chhaya on 19 January 2018. BellaSeno is a preclinical company using 3D printing to create scaffolds for breast reconstruction.
Platoscience Neurostimulation, based out of Copenhagen, unveiled several headsets designed to help users create or concentrate on a given task at CES 2018.
The Reliefband is a non-invasive, drug free device work on the wrist that provides gentle neuromodulation to the medial nerve.